192
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Bergamot oil as an integral component of nanostructured lipid carriers and a photosensitizer for photodynamic treatment of vitiligo: Characterization and clinical experimentation

, ORCID Icon, , &
Pages 139-150 | Received 08 Aug 2020, Accepted 27 Oct 2020, Published online: 11 Nov 2020

References

  • Fadel M, Samy N, Nasr M, et al. Topical colloidal indocyanine green-mediated photodynamic therapy for treatment of basal cell carcinoma. Pharm Dev Technol. 2017;22(4):545–550.
  • Morton C, Szeimies R-M, Basset‐Séguin N, et al., European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications – field cancerization, photorejuvenation and inflammatory/infective dermatoses. J Eur Acad Dermatol Venereol. 34(1): 17–29. 2020.
  • Bsieso EA, Nasr M, Moftah NH, et al. Could nanovesicles containing a penetration enhancer clinically improve the therapeutic outcome in skin fungal diseases? Nanomedicine (Lond). 2015;10(13):2017–2031.
  • Nasr M, Abdel-Hamid S, Moftah NH, et al. Jojoba oil soft colloidal nanocarrier of a synthetic retinoid: preparation, characterization and clinical efficacy in psoriatic patients. Curr Drug Deliv. 2017;14(3):426–432.
  • Ramez SA, Soliman MM, Fadel M, et al. Novel methotrexate soft nanocarrier/fractional erbium YAG laser combination for clinical treatment of plaque psoriasis. Artif Cells Nanomed Biotechnol. 2018;46(sup1):996–1002.
  • Hatem S, Nasr M, Moftah NH, et al. Melatonin vitamin C-based nanovesicles for treatment of androgenic alopecia: design, characterization and clinical appraisal. Eur J Pharm Sci. 2018;122:246–253.
  • Sinico C, Valenti D, Manconi M. et al. Cutaneous delivery of 8-methoxypsoralen from liposomal and niosomal carriers. J Drug Deliv Sci Tech. 2006;16(2):115–120.
  • Primo FL, Bentley MV, Tedesco AC. Photophysical studies and in vitro skin permeation/retention of Foscan®/nanoemulsion (NE) applicable to photodynamic therapy skin cancer treatment. J Nanosci Nanotechnol. 2008;8(1):340–347.
  • Fang J-Y, Fang C-L, Liu C-H, et al. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 2008;70(2):633–640.
  • Kristl J, Volk B, Gašperlin M, et al. Effect of colloidal carriers on ascorbyl palmitate stability. Eur J Pharm Sci. 2003;19(4):181–189.
  • Lima AM, Dal Pizzol C, Monteiro FBF, et al. Hypericin encapsulated in solid lipid nanoparticles: phototoxicity and photodynamic efficiency. Journal of Photochemistry and Photobiology B: Biology. 2013;125:146–154.
  • Youssef T, Fadel M, Fahmy R, et al. Evaluation of hypericin-loaded solid lipid nanoparticles: physicochemical properties, photostability and phototoxicity. Pharm Dev Technol. 2012;17(2):177–186.
  • Raza K, Singh B, Lohan S, et al. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Int J Pharm. 2013;456(1):65–72.
  • Kamel AE, Fadel M, Louis D. <p>Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line. <![cdata[international Journal of Nanomedicine]]>. 2019;14:5073.
  • Müller R, Petersen R, Hommoss A, et al. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev. 2007;59(6):522–530.
  • Amer SS, Nasr M, Mamdouh W, et al. Insights on the use of nanocarriers for acne alleviation. Curr Drug Deliv. 2018;16(1):18–25.
  • Bseiso EA, Nasr M, Abd El Gawad N, et al. Recent advances in topical formulation carriers of antifungal agents. Indian J Dermatol Venereol Leprol. 2015;81(5):457–463.
  • Li Y, Wu Z-F, Kuang -W-W, et al. Effect of nanostructured lipid carriers (NLCs) in improving stability of essential oils and its application. Zhongguo Zhong Yao Za Zhi. 2020;45(3):523–530.
  • Montenegro L, Pasquinucci L, Zappala A, et al. Rosemary essential oil-loaded lipid nanoparticles: in vivo topical activity from gel vehicles. Pharmaceutics. 2017;9(4):48.
  • Nahr FK, Ghanbarzadeh B, Hamishehkar H, et al. Food grade nanostructured lipid carrier for cardamom essential oil: preparation, characterization and antimicrobial activity. J Funct Foods. 2018;40:1–8.
  • Nahr FK, Ghanbarzadeh B, Kafil HS, et al. The colloidal and release properties of cardamom oil encapsulated nanostructured lipid carrier. J Disper Sci Technol. 2019. DOI:10.1080/01932691.2019.1658597.
  • Bashiri S, Ghanbarzadeh B, Ayaseh A, et al. Essential oil-loaded nanostructured lipid carriers: the effects of liquid lipid type on the physicochemical properties in beverage models. Food Bioscience. 2020;35:100526.
  • Serrano-Pérez JJ, González-Luque R, Merchán M, et al. The family of furocoumarins: looking for the best photosensitizer for phototherapy. Journal of Photochemistry and Photobiology A: Chemistry. 2008;199(1):34–41.
  • Kinley JS, Moan J, Dall’Aqua F, et al. Quantitative assessment of epidermal melanogenesis in C3H/Tif hr/hr mice treated with topical furocoumarins and UVA radiation. J Invest Dermatol. 1994;103(1):97–103.
  • Towers G, Page J, Hudson J. Light-mediated biological activities of natural products from plants and fungi. Curr Org Chem. 1997;1:395–414.
  • Kejlová K, Jírová D, Bendová H, et al. Phototoxicity of bergamot oil assessed by in vitro techniques in combination with human patch tests. Toxicol In Vitro. 2007;21(7):1298–1303.
  • Zaynoun S, Johnson B, Frain-Bell W. A study of oil of bergamot and its importance as a phototoxic agent. Contact Derm. 1977;3(5):225–239.
  • Kanwar AJ, Dogra S, Parsad D, et al. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy. Int J Dermatol. 2005;44(1):57–60.
  • Al-Saedy SJ, Al-Hilo MM. Treatment of Vitiligo with Narrow Band UVB vs. UVB with 0.1% Psoralin; A Case Controlled, Comparative, Therapeutic Trial. Am J Dermatol Venereol. 2012;1(2):30–34.
  • Shaaban M, Nasr M, Tawfik AA, et al. Novel bergamot oil nanospanlastics combined with PUVB therapy as a clinically translatable approach for vitiligo treatment. Drug Deliv Transl Res. 2019;9(6):1106–1116.
  • Bansal S, Sahoo B, Garg GV. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone. Photodermatology, Photoimmunology & Photomedicine. 2015;81(5):311–317.
  • Fang Y-P, Lin Y-K, Su Y-H, et al. Tryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: the effects of solid lipid/liquid lipid ratios in the inner core. Chem Pharm Bull. 2011;59(2):266–271.
  • Zhu J, Zhuang P, Luan L, et al. Preparation and characterization of novel nanocarriers containing krill oil for food application. J Funct Foods. 2015;19:902–912.
  • Gabal YM, Kamel AO, Sammour OA, et al. Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route. Int J Pharm. 2014;473(1):442–457.
  • Hu F-Q, Jiang S-P, Du Y-Z, et al. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B. 2005;45(3):167–173.
  • Hu F-Q, Jiang S-P, Du Y-Z, et al. Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm. 2006;314(1):83–89.
  • Hatem S, Nasr M, Moftah NH, et al. Clinical cosmeceutical repurposing of melatonin in androgenic alopecia using nanostructured lipid carriers prepared with antioxidant oils. Expert Opin Drug Deliv. 2018;15(10):927–935.
  • Nasr M, Mansour S, Mortada D, et al. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul. 2008;25(7):499–512.
  • Abdelgawad R, Nasr M, Moftah NH, et al. Phospholipid membane tubulation using ceramide doping “Cerosomes”: characterization and clinical application in psoriasis treatment. Eur J Pharm Sci. 2017;101:258–268.
  • Khurana S, Jain N, Bedi P. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam. Life Sci. 2013;93(21):763–772.
  • Gambhire M, Bhalekar M, Shrivastava B. Investigations in photostability of dithranol incorporated in solid lipid nanoparticles. Pharm Chem J. 2012;46(4):256–261.
  • Weiss-Angeli V, Poletto F, Zancan L. et al. Nanocapsules of octyl methoxycinnamate containing quercetin delayed the photodegradation of both components under ultraviolet A radiation. J Biom Nanotechnol. 2008;4(1):80–89.
  • Sapam R, Agrawal S, Dhali TK. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study. Int J Dermatol. 2012;51(9):1107–1115.
  • Bhatnagar A, Kanwar A, Parsad D. et al. Comparison of systemic PUVA and NB‐UVB in the treatment of vitiligo: an open prospective study. J Eur Acad Dermatol. 2007;21(5):638–642.
  • Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg. 2004;30(2):130–135.
  • Schubert M, Müller-Goymann C. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm. 2005;61(1):77–86.
  • Lopes R, Eleutério C, Gonçalves L, et al. Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. Eur J Pharm Sci. 2012;45(4):442–450.
  • Kovacevic A, Savic S, Vuleta G, et al. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm. 2011;406(1):163–172.
  • Bunjes H, Koch MH, Westesen K. Influence of emulsifiers on the crystallization of solid lipid nanoparticles. J Pharm Sci. 2003;92(7):1509–1520.
  • Das S, Ng WK, Tan RB. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci. 2012;47(1):139–151.
  • Münster U, NakamuraNachname C, Haberland A, et al. RU 58841-myristate–prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie. 2005;60(1):8–12.
  • Ashraf A, Mahmoud PA, Reda H, et al. Silymarin and silymarin nanoparticles guard against chronic unpredictable mild stress induced depressive-like behavior in mice: involvement of neurogenesis and NLRP3 inflammasome. J Psychopharmacol. 2019;33(5):615–631.
  • Kovačević AB, Müller RH, Savić SD, et al. Solid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: preparation, characterization and physical stability investigation. Colloids Surf A Physicochem Eng Asp. 2014;444:15–25.
  • Keck CM, Kovačević A, Müller RH, et al. Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants. Int J Pharm. 2014;474(1):33–41.
  • Das S, Ng WK, Tan RB. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers: I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles. Nanotechnology. 2014;25(10):105101.
  • Tsai M-J, Wu P-C, Huang Y-B, et al. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm. 2012;423(2):461–470.
  • Han F, Li S, Yin R, et al. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers. Colloids Surf A Physicochem Eng Asp. 2008;315(1):210–216.
  • Bhalekar MR, Pokharkar V, Madgulkar A, et al. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS Pharmscitech. 2009;10(1):289–296.
  • Loo CH, Basri M, Ismail R, et al. Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion. Int J Nanomed. 2013;8:13.
  • Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2):165–196.
  • Trotta M, Gallarate M, Pattarino F, et al. Investigation of the phase behaviour of systems containing lecithin and 2-acyl lysolecithin derivatives. Int J Pharm. 1999;190(1):83–89.
  • Soddu E, Rassu G, Cossu M, et al. The effect of formulative parameters on the size and physical stability of SLN based on “green” components. Pharm Dev Technol. 2016;21(1):98-107.
  • Tan S, Billa N, Roberts C, et al. Surfactant effects on the physical characteristics of Amphotericin B-containing nanostructured lipid carriers. Colloids Surf A Physicochem Eng Asp. 2010;372(1):73–79.
  • Huang Z-R, Hua S-C, Yang Y, et al. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol Sin. 2008;29(9):1094–1102.
  • Savic S, Pantelic I, Lukic M. Behind the Alkyl Polyglucoside-based structures: lamellar liquid crystalline and lamellar gel phases in different emulsion systems. In: Pantelic I, editor. Alkyl Polyglucosides: from natural-origin surfactants to prospective delivery systems. Cambridge: Woodhead publishing, elsevier; 2014. p. 21.
  • Teeranachaideekul V, Souto EB, Müller RH, et al. Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels). J Microencapsul. 2008;25(2):111–120.
  • Savic S, Lukic M, Jaksic I, et al. An alkyl polyglucoside-mixed emulsifier as stabilizer of emulsion systems: the influence of colloidal structure on emulsions skin hydration potential. J Colloid Interface Sci. 2011;358(1):182–191.
  • Schwarz JC, Weixelbaum A, Pagitsch E, et al. Nanocarriers for dermal drug delivery: influence of preparation method, carrier type and rheological properties. Int J Pharm. 2012;437(1):83–88.
  • Mitri K, Shegokar R, Gohla S, et al. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Int J Pharm. 2011;414(1):267–275.
  • Sapino S, Carlotti M, Pelizzetti E, et al. Protective effect of SLNs encapsulation on the photodegradation and thermal degradation of retinyl palmitate introduced in hydroxyethylcellulose gel. J Drug Deliv Sci Technol. 2005;15(2):159–165.
  • Müller R, Radtke M, Wissing S. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 2002;242(1):121–128.
  • Wissing S, Müller R. The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles. Int J Pharm. 2002;242(1):373–375.
  • Garg BJ, Garg NK, Beg S, et al. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment. J Drug Target. 2016;24(3):233–246.
  • Patel NS, Paghdal KV, Cohen GF. Advanced treatment modalities for vitiligo. Dermatolo Surg. 2012;38(3):381–391.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.